<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Lsl Pharma Group Inc. — News on 6ix</title>
    <link>https://6ix.com/company/lsl-pharma-group-inc</link>
    <description>Latest news and press releases for Lsl Pharma Group Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 30 Apr 2026 11:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/lsl-pharma-group-inc" rel="self" type="application/rss+xml" />
    <item>
      <title>LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2025 RESULTS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-its-fourth-quarter-and-year-end-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-its-fourth-quarter-and-year-end-2025-results</guid>
      <pubDate>Thu, 30 Apr 2026 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2025 RESULTS         Canada NewsWire    ...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP INC. ANNOUNCES ITS PARTICIPATION IN THE &quot;2026 BLOOM BURTON &amp; CO. HEALTHCARE INVESTOR CONFERENCE&quot;</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-inc-announces-its-participation-in-the-2026-bloom-burton-and-co-healthcare-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-inc-announces-its-participation-in-the-2026-bloom-burton-and-co-healthcare-investor-conference</guid>
      <pubDate>Wed, 15 Apr 2026 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP INC. ANNOUNCES ITS PARTICIPATION IN THE &quot;2026 BLOOM BURTON &amp;amp; CO. HEALTHCARE ...</description>
    </item>
    <item>
      <title>JUNO OTC, A WHOLLY-OWNED SUBSIDIARY OF LSL PHARMA GROUP, SIGNS BINDING TERM SHEET WITH INSTAPILL PRIVATE LIMITED TO SUPPLY PRIVATE LABEL LORATADINE 10 MG RDT IN CANADA</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/juno-otc-a-wholly-owned-subsidiary-of-lsl-pharma-group-signs-binding-term-sheet-with-instapill-private-limited-to-supply-private-label-loratadine-10-mg-rdt-in-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/juno-otc-a-wholly-owned-subsidiary-of-lsl-pharma-group-signs-binding-term-sheet-with-instapill-private-limited-to-supply-private-label-loratadine-10-mg-rdt-in-canada</guid>
      <pubDate>Thu, 09 Apr 2026 11:00:00 GMT</pubDate>
      <description>JUNO OTC, A WHOLLY-OWNED SUBSIDIARY OF LSL PHARMA GROUP, SIGNS BINDING TERM SHEET WITH INSTAPILL ...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP GRANTS STOCK OPTIONS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-grants-stock-214900277</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-grants-stock-214900277</guid>
      <pubDate>Tue, 03 Feb 2026 21:49:00 GMT</pubDate>
      <description>LSL PHARMA GROUP INC. (TSXV: LSL) (The &quot;Corporation&quot; or &quot;LSL Pharma&quot;), a Canadian integrated pharmaceutical company, announced today that it has granted an aggregate of 960,000 stock options (&quot;Options&quot;) to its non-executive directors and to certain executives and employees, as part of their compensation. The Options have an exercise price of CAD $0.52 per share and are exercisable for a period of ten-(10) years from the date of grant. Options granted to non-executive directors vest immediately a</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-successfully-obtained-us-fda-certification-for-the-manufacturing-of-ophthalmic-ointments-for-commercialization-in-the-united-states</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-successfully-obtained-us-fda-certification-for-the-manufacturing-of-ophthalmic-ointments-for-commercialization-in-the-united-states</guid>
      <pubDate>Wed, 28 Jan 2026 12:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-closing-of-the-acquisition-of-juno-otc-and-final-dollar2m-closing-of-upsized-dollar12m-offering</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-closing-of-the-acquisition-of-juno-otc-and-final-dollar2m-closing-of-upsized-dollar12m-offering</guid>
      <pubDate>Tue, 23 Dec 2025 22:20:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZE...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP CLOSES $10M OF UPSIZED $12M BROKERED OFFERING AND ENTERS INTO DEFINITIVE AGREEMENT FOR THE ACQUISITION OF JUNO OTC</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-closes-dollar10m-of-upsized-dollar12m-brokered-offering-and-enters-into-definitive-agreement-for-the-acquisition-of-juno-otc</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-closes-dollar10m-of-upsized-dollar12m-brokered-offering-and-enters-into-definitive-agreement-for-the-acquisition-of-juno-otc</guid>
      <pubDate>Tue, 23 Dec 2025 14:11:00 GMT</pubDate>
      <description>LSL PHARMA GROUP CLOSES $10M OF UPSIZED $12M BROKERED OFFERING AND ENTERS INTO DEFINITIVE AGREEME...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ANNOUNCES ACQUISITION OF JUNO OTC INC. AND A BROKERED PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURES OF $11M</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-acquisition-of-juno-otc-inc-and-a-brokered-private-placement-of-convertible-debentures-of-dollar11m</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-acquisition-of-juno-otc-inc-and-a-brokered-private-placement-of-convertible-debentures-of-dollar11m</guid>
      <pubDate>Wed, 17 Dec 2025 12:30:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ANNOUNCES ACQUISITION OF JUNO OTC INC. AND A BROKERED PRIVATE PLACEMENT OF CONVE...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-fourth-consecutive-record-quarterly-revenues-and-q3-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-fourth-consecutive-record-quarterly-revenues-and-q3-2025-financial-results</guid>
      <pubDate>Thu, 20 Nov 2025 12:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESUL...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-completes-the-acquisition-of-laboratoire-du-var-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-completes-the-acquisition-of-laboratoire-du-var-inc</guid>
      <pubDate>Tue, 18 Nov 2025 12:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.         Canada NewsWire    ...</description>
    </item>
    <item>
      <title>HEALTH CANADA GRANTS LSL PHARMA GROUP APPROVAL TO COMMERCIALIZE SIX NEW STERILE OPHTHALMIC SOLUTIONS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/health-canada-grants-lsl-pharma-group-approval-to-commercialize-six-new-sterile-ophthalmic-solutions</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/health-canada-grants-lsl-pharma-group-approval-to-commercialize-six-new-sterile-ophthalmic-solutions</guid>
      <pubDate>Tue, 28 Oct 2025 11:00:00 GMT</pubDate>
      <description>HEALTH CANADA GRANTS LSL PHARMA GROUP APPROVAL TO COMMERCIALIZE SIX NEW STERILE OPHTHALMIC SOLUTI...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ANNOUNCES APPOINTMENTS TO ITS BOARD OF DIRECTORS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-appointments-to-its-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-appointments-to-its-board-of-directors</guid>
      <pubDate>Thu, 16 Oct 2025 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ANNOUNCES APPOINTMENTS TO ITS BOARD OF DIRECTORS         Canada NewsWire        ...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP CLOSES A $2.275M NON-BROKERED PRIVATE PLACEMENT</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-closes-a-dollar2275m-non-brokered-private-placement</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-closes-a-dollar2275m-non-brokered-private-placement</guid>
      <pubDate>Tue, 02 Sep 2025 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP CLOSES A $2.275M NON-BROKERED PRIVATE PLACEMENT           Canada NewsWire       ...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP REPORTS THIRD CONSECUTIVE RECORD QUARTERLY REVENUES AND Q2 2025 FINANCIAL RESULTS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-third-consecutive-record-quarterly-revenues-and-q2-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-third-consecutive-record-quarterly-revenues-and-q2-2025-financial-results</guid>
      <pubDate>Mon, 25 Aug 2025 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP REPORTS THIRD CONSECUTIVE RECORD QUARTERLY REVENUES AND Q2 2025 FINANCIAL RESULT...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ANNOUNCES THE COMPLETION OF EARLY REDEMPTION OF ALL 11% UNSECURED CONVERTIBLE DEBENTURES</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-the-completion-of-early-redemption-of-all-11percent-unsecured-convertible-debentures</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-the-completion-of-early-redemption-of-all-11percent-unsecured-convertible-debentures</guid>
      <pubDate>Mon, 04 Aug 2025 20:45:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ANNOUNCES THE COMPLETION OF EARLY REDEMPTION OF ALL 11% UNSECURED CONVERTIBLE DE...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ENTERS INTO NON-BINDING AGREEMENT TO ACQUIRE A QUEBEC-BASED COMPETITOR</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-enters-into-non-binding-agreement-to-acquire-a-quebec-based-competitor</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-enters-into-non-binding-agreement-to-acquire-a-quebec-based-competitor</guid>
      <pubDate>Thu, 31 Jul 2025 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ENTERS INTO NON-BINDING AGREEMENT TO ACQUIRE A QUEBEC-BASED COMPETITOR          ...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ANNOUNCES REDEMPTION OF 11% UNSECURED CONVERTIBLE DEBENTURES</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-redemption-of-11percent-unsecured-convertible-debentures</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-redemption-of-11percent-unsecured-convertible-debentures</guid>
      <pubDate>Wed, 02 Jul 2025 23:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ANNOUNCES REDEMPTION OF 11% UNSECURED CONVERTIBLE DEBENTURES           Canada Ne...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-voting-results-of-its-annual-general-and-special-meeting-of-shareholders</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-announces-voting-results-of-its-annual-general-and-special-meeting-of-shareholders</guid>
      <pubDate>Fri, 27 Jun 2025 23:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDE...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-secures-dollar175-million-from-desjardins-and-bdc</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-secures-dollar175-million-from-desjardins-and-bdc</guid>
      <pubDate>Fri, 27 Jun 2025 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC           Canada NewsWire         ...</description>
    </item>
    <item>
      <title>LSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2025 RESULTS</title>
      <link>https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-record-revenues-and-first-quarter-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/lsl-pharma-group-inc/news/lsl-pharma-group-reports-record-revenues-and-first-quarter-2025-results</guid>
      <pubDate>Thu, 29 May 2025 11:00:00 GMT</pubDate>
      <description>LSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2025 RESULTS           Canada NewsWire...</description>
    </item>
  </channel>
</rss>